Breast cancer consists of the transformation of benign cells in malign cells that grow in an autonomous and disorderly form in the mammary tissue. Breast cancer constitutes one of the more frequent neoplasias in the world, it is estimated that one in each eight women will be diagnosed with this disease.

Among the main risk factors are age and gender, more than 80% of all cases occur in women over 45 years and less than 1% happen in men. Women who initiate their menstrual periods early, before the age of 11, or arrive at menopause after 55, have a greater risk, the same thing happens if they do not have children or they had them after 30 years of age. Other risk factors are: use of oral contraceptives, prolonged administration of available hormonal therapy, obesity, exaggerated alcohol consumption, exposure to chemical substances similar to estrogens (found in pesticides and certain industrial products), exposure to radiation, the presence of predisposing genes, antecedent of previous tumors in breasts, uterus, ovaries or colon, and past history cancer in the family.

When this disease is diagnosed, there may not be any symptoms. But while it grows, the following changes may occur: a bulk or thickening near the breast or in the area below the arm or neck; change in the size or forms of the breast; secretion or bother in the nipple, ridges in the breast's skin, like an orange's skin; changes in the form or sensitivity of the skin of the breast, aureole or nipple, like for example increase in temperature, reddening and inflammation.

Once the tumor is diagnosed and classified, the follow-up is analyzed, which could be: a conservative treatment that consists in extirpating the tumor as well as a security margin of healthy mammary tissue. A conservative therapy would also include radio therapy later. The radical treatment consists in the extirpation of all the mammary tissue, including areola and nipple. Both the conservative and radical strategies also include the elimination of the axilla's lymphatic ganglions. In the case of lymphatic dissemination hormone and chemo therapy are used, treatments that may produce important collateral effects.

Even though there are massive information and awareness procedures against breast cancer (auto-examination, medical evaluation, mammography, etc.) and the existence of innovative and ever more aggressive treatments for the disease, these have not been able to significantly decrease morbi-mortality.

The scientific world has not managed to establish definitive therapeutic strategies that provide as a result a cure, nevertheless, everything points out that if therapies are obtained which increase the host's immunological competitiveness, there will be greater possibilities of beating the tumor and obtaining a remission of the neoplasia. If to this we add selective antitumoral-like therapies which act against possible causal agents, we will be close to obtaining the "suitable treatment" that has been looked for exhaustively, during so many years, without still obtaining an answer.

Chemo and x-ray therapy debilitate or eliminate neoplasic cells, but they also affect healthy cells. For that reason, in many occasions they worsen the condition that is assumed they would cure. Medicinal plants -to a certain extent- resist the indirect effects of chemotherapy, such as: hair loss, nausea, vomits, depression, and others, helping with it to partially avoid the patient's collapse.

In the Adaptogenic Educational Medical Centers and Units, a clinical study was carried out to evaluate the effectiveness of the Systemic treatment, through a retrospective analysis of medical histories of patients with breast cancer. This study determined that the indirect effects attributable to chemo and radio appeared in a smaller percentage of the patients.

Medullar Aplasia, diarrhea nor hair loss was observed and blood transfusions were not required in any of the patients. The great majority of patients improved their of Quality of Life indices after initiating the treatment with a combination of superior plants: 91.18% of the patients declared feeling physical and mental well-being and greater energy; 85.29% had an increase in appetite and 76.47% referred to present/display reparative sleep, excreta improvement and return to daily activities, including work.

These findings allow us to conclude that the use of adaptogens, in combination with conventional treatments, under the optics of the Systemic Medicine, boosts the beneficial effects, diminishing the undesirable effects attributed to chemo and radio therapies. In addition it preserved and/or improved the quality of life of the patients with breast cancer who fulfilled the established treatment.

In view that a high number of patients with mammary cancer treated with chemotherapy passes away because of infections related to Neutropenia and other indirect effects induced by this treatment, it is possible to expect an important reduction in the morbi-mortality of patients who fulfill the Systemic treatment.